CDKN2A and glioblastoma: In contrast to entire cohort of GBM samples, we found a near significant or significant downregulation of ANRIL, CDKN2A and CDKN2B in GBMs with homozygous INK4a/INK4b co-deletion compared to that of control brain samples (Supplementary Figure 7A–7C).